FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to daidzein derivative of formula (I) or a pharmaceutically acceptable salt thereof, where R1 and R2 each independently denote H or C1-10alkyl; n equals 1, 2, 3, 4 or 5 and daidzein derivative does not include 7-O-N,N-dimethyl-aminobutyryl-daidzein, as well as to a method for production thereof, a pharmaceutical composition based on disclosed compounds and use thereof for treating vascular-cardiac diseases.
EFFECT: as compared to traditional hydrochloride daidzein derivative, produced according to this invention 7-O-N,N-diethyl-aminoacetyl daidzein hydrochloride has better solubility and best effect in treating cardiovascular diseases.
11 cl, 7 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2261708C2 |
| PYRAZOLE DERIVATIVE | 2014 |
|
RU2632884C2 |
| PHARMACEUTICAL COMPOSITION FOR HYPERLIPIDEMIA TREATMENT | 2014 |
|
RU2623876C2 |
| PYRIDINE CARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2015 |
|
RU2694899C2 |
| AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2185381C2 |
| SUBSTITUTED DERIVATIVE OF AMIDINOBENZENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2158263C2 |
| PHARMACEUTICAL COMPOSITION WITH TELMISARTAN SODIUM SALT | 2004 |
|
RU2372918C2 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDEMIA | 2017 |
|
RU2683641C2 |
| DERIVATIVES OF BENZOYLGUANIDINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF ITS PREPARING | 1995 |
|
RU2158255C2 |
| NAPHTHYL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE SUBSTANCES | 1996 |
|
RU2167849C2 |
